“The global eClinical solutions market is estimated to grow at a high CAGR of 12.1% from 2015 to 2020. Although developed regions (such as North America and Europe) held large shares in the eClinical solutions market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 16.1% in the next five years. Factors such as the increasing outsourcing of clinical trial studies by the large pharma and biopharma companies in Asia-Pacific countries, presence of large patient population, and low operating cost in conducting clinical trials are propelling the growth of the eClinical solutions market in this region.
The growth of the global eClinical solutions market is driven by factors such as rising adoption of software solutions during clinical trials, increasing R&D expenditure by pharmaceutical companies, growing government grants to support clinical research, and rising customer base. In addition, increasing clinical research in emerging Asian countries, shift of clinical trials and resources from AMCs to CROs, and developments of cost effective modules are offering new growth opportunities for the eClinical solutions vendors. Nonetheless, the high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are the key reasons hampering the growth of the eClinical solutions market. Besides, low software adoption rate in several geographic such as Middle East and Africa, and software reliability and patient privacy issues are also restricting the growth of the eClinical solutions market.
For complete report please visit :http://www.gosreports.com/eclinical-solutions-market-by-product-cdms-edc-ctms-ecoa-analytics-rtms-etmf-safety-delivery-mode-web-hosted-on-premise-cloud-based-clinical-trial-phases-end-user-pharmabiopharma-com/
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16